CINCINNATI (FOX19) - Ohio Gov. Mike DeWine and top state health officials are advising all Ohio vaccine providers to temporarily pause using the Johnson & Johnson (Janssen) vaccine, his office announced Tuesday.
Ohio has used its J&J vaccines mostly at colleges and mass vaccine sites like the Cintas Center.
The Cintas Center is pausing COVID-19 vaccines this week following the news about the Johnson & Johnson vaccine review.
The University of Cincinnati’s on-campus student clinic is switching from the J&J vaccine to the Pfizer.
Miami will offer vaccination clinics for its students on April 10, 11, 15 and 16. Miami University has received 3,500 doses of the Pfizer COVID-19 vaccine from the State of Ohio that are designated for students. Pfizer is a two-dose vaccine; the second dose will be offered May 1, 2, 6 and 8.
Locally, Hamilton County Public Health is halting the use of the Johnson & Johnson COVID-19 vaccine until further notice out of an abundance of caution, the agency spokesman tells FOX19 NOW.
The decision comes after reports of six people experiencing unusual clots in the days after getting the single-dose J&J vaccine, according to officials.
The symptoms appeared in the six women, between 18 and 48, around six to 14 days after vaccination, health officials said.
Around 6.8 million people have received the J&J vaccine in the United States. Ohio has received around 264,000 doses.
Ohio’s Dr. Bruce Vanderhoff said these reaction cases are “extremely rare.”
The symptoms in the cases include severe headaches, abdominal or leg pain, or shortness of breath. Anyone who develops the symptoms needs to seek medical care.
Pausing the Johnson & Johnson vaccine is believed to last days, maybe a week, Gov. DeWine said.
See a spelling or grammar error in our story? Click here to report it. Please include title of story.